Database-guided discovery of potent peptides to combat HIV-1 or superbugs

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Antimicrobial peptides (AMPs), small host defense proteins, are indispensable for the protection of multicellular organisms such as plants and animals from infection. The number of AMPs discovered per year increased steadily since the 1980s. Over 2,000 natural AMPs from bacteria, protozoa, fungi, plants, and animals have been registered into the antimicrobial peptide database (APD). The majority of these AMPs (>86%) possess 11-50 amino acids with a net charge from 0 to +7 and hydrophobic percentages between 31-70%. This article summarizes peptide discovery on the basis of the APD. The major methods are the linguistic model, database screening, de novo design, and template-based design. Using these methods, we identified various potent peptides against human immunodeficiency virus type 1 (HIV-1) or methicillin-resistant Staphylococcus aureus (MRSA). While the stepwise designed anti-HIV peptide is disulfide-linked and rich in arginines, the ab initio designed anti-MRSA peptide is linear and rich in leucines. Thus, there are different requirements for antiviral and antibacterial peptides, which could kill pathogens via different molecular targets. The biased amino acid composition in the database-designed peptides, or natural peptides such as θ-defensins, requires the use of the improved two-dimensional NMR method for structural determination to avoid the publication of misleading structure and dynamics. In the case of human cathelicidin LL-37, structural determination requires 3D NMR techniques. The high-quality structure of LL-37 provides a solid basis for understanding its interactions with membranes of bacteria and other pathogens. In conclusion, the APD database is a comprehensive platform for storing, classifying, searching, predicting, and designing potent peptides against pathogenic bacteria, viruses, fungi, parasites, and cancer cells.

Original languageEnglish (US)
Pages (from-to)728-758
Number of pages31
JournalPharmaceuticals
Volume6
Issue number6
DOIs
StatePublished - Jun 5 2013

Fingerprint

HIV-1
Databases
Peptides
Methicillin-Resistant Staphylococcus aureus
Bacteria
Fungi
Defensins
Amino Acids
Linguistics
Leucine
Disulfides
Antiviral Agents
Arginine
Publications
Parasites
HIV
Viruses

Keywords

  • Ab initio design
  • Antimicrobial peptides
  • Biofilms
  • Database screening
  • De novo design
  • HIV-1
  • Improved 2D NMR method
  • MRSA
  • Superbugs
  • Template-based design

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science

Cite this

Database-guided discovery of potent peptides to combat HIV-1 or superbugs. / Wang, Guangshun.

In: Pharmaceuticals, Vol. 6, No. 6, 05.06.2013, p. 728-758.

Research output: Contribution to journalArticle

@article{97bb57f36f76466a9fb63b124f57954d,
title = "Database-guided discovery of potent peptides to combat HIV-1 or superbugs",
abstract = "Antimicrobial peptides (AMPs), small host defense proteins, are indispensable for the protection of multicellular organisms such as plants and animals from infection. The number of AMPs discovered per year increased steadily since the 1980s. Over 2,000 natural AMPs from bacteria, protozoa, fungi, plants, and animals have been registered into the antimicrobial peptide database (APD). The majority of these AMPs (>86{\%}) possess 11-50 amino acids with a net charge from 0 to +7 and hydrophobic percentages between 31-70{\%}. This article summarizes peptide discovery on the basis of the APD. The major methods are the linguistic model, database screening, de novo design, and template-based design. Using these methods, we identified various potent peptides against human immunodeficiency virus type 1 (HIV-1) or methicillin-resistant Staphylococcus aureus (MRSA). While the stepwise designed anti-HIV peptide is disulfide-linked and rich in arginines, the ab initio designed anti-MRSA peptide is linear and rich in leucines. Thus, there are different requirements for antiviral and antibacterial peptides, which could kill pathogens via different molecular targets. The biased amino acid composition in the database-designed peptides, or natural peptides such as θ-defensins, requires the use of the improved two-dimensional NMR method for structural determination to avoid the publication of misleading structure and dynamics. In the case of human cathelicidin LL-37, structural determination requires 3D NMR techniques. The high-quality structure of LL-37 provides a solid basis for understanding its interactions with membranes of bacteria and other pathogens. In conclusion, the APD database is a comprehensive platform for storing, classifying, searching, predicting, and designing potent peptides against pathogenic bacteria, viruses, fungi, parasites, and cancer cells.",
keywords = "Ab initio design, Antimicrobial peptides, Biofilms, Database screening, De novo design, HIV-1, Improved 2D NMR method, MRSA, Superbugs, Template-based design",
author = "Guangshun Wang",
year = "2013",
month = "6",
day = "5",
doi = "10.3390/ph6060728",
language = "English (US)",
volume = "6",
pages = "728--758",
journal = "Pharmaceuticals",
issn = "1424-8247",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "6",

}

TY - JOUR

T1 - Database-guided discovery of potent peptides to combat HIV-1 or superbugs

AU - Wang, Guangshun

PY - 2013/6/5

Y1 - 2013/6/5

N2 - Antimicrobial peptides (AMPs), small host defense proteins, are indispensable for the protection of multicellular organisms such as plants and animals from infection. The number of AMPs discovered per year increased steadily since the 1980s. Over 2,000 natural AMPs from bacteria, protozoa, fungi, plants, and animals have been registered into the antimicrobial peptide database (APD). The majority of these AMPs (>86%) possess 11-50 amino acids with a net charge from 0 to +7 and hydrophobic percentages between 31-70%. This article summarizes peptide discovery on the basis of the APD. The major methods are the linguistic model, database screening, de novo design, and template-based design. Using these methods, we identified various potent peptides against human immunodeficiency virus type 1 (HIV-1) or methicillin-resistant Staphylococcus aureus (MRSA). While the stepwise designed anti-HIV peptide is disulfide-linked and rich in arginines, the ab initio designed anti-MRSA peptide is linear and rich in leucines. Thus, there are different requirements for antiviral and antibacterial peptides, which could kill pathogens via different molecular targets. The biased amino acid composition in the database-designed peptides, or natural peptides such as θ-defensins, requires the use of the improved two-dimensional NMR method for structural determination to avoid the publication of misleading structure and dynamics. In the case of human cathelicidin LL-37, structural determination requires 3D NMR techniques. The high-quality structure of LL-37 provides a solid basis for understanding its interactions with membranes of bacteria and other pathogens. In conclusion, the APD database is a comprehensive platform for storing, classifying, searching, predicting, and designing potent peptides against pathogenic bacteria, viruses, fungi, parasites, and cancer cells.

AB - Antimicrobial peptides (AMPs), small host defense proteins, are indispensable for the protection of multicellular organisms such as plants and animals from infection. The number of AMPs discovered per year increased steadily since the 1980s. Over 2,000 natural AMPs from bacteria, protozoa, fungi, plants, and animals have been registered into the antimicrobial peptide database (APD). The majority of these AMPs (>86%) possess 11-50 amino acids with a net charge from 0 to +7 and hydrophobic percentages between 31-70%. This article summarizes peptide discovery on the basis of the APD. The major methods are the linguistic model, database screening, de novo design, and template-based design. Using these methods, we identified various potent peptides against human immunodeficiency virus type 1 (HIV-1) or methicillin-resistant Staphylococcus aureus (MRSA). While the stepwise designed anti-HIV peptide is disulfide-linked and rich in arginines, the ab initio designed anti-MRSA peptide is linear and rich in leucines. Thus, there are different requirements for antiviral and antibacterial peptides, which could kill pathogens via different molecular targets. The biased amino acid composition in the database-designed peptides, or natural peptides such as θ-defensins, requires the use of the improved two-dimensional NMR method for structural determination to avoid the publication of misleading structure and dynamics. In the case of human cathelicidin LL-37, structural determination requires 3D NMR techniques. The high-quality structure of LL-37 provides a solid basis for understanding its interactions with membranes of bacteria and other pathogens. In conclusion, the APD database is a comprehensive platform for storing, classifying, searching, predicting, and designing potent peptides against pathogenic bacteria, viruses, fungi, parasites, and cancer cells.

KW - Ab initio design

KW - Antimicrobial peptides

KW - Biofilms

KW - Database screening

KW - De novo design

KW - HIV-1

KW - Improved 2D NMR method

KW - MRSA

KW - Superbugs

KW - Template-based design

UR - http://www.scopus.com/inward/record.url?scp=84878419915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878419915&partnerID=8YFLogxK

U2 - 10.3390/ph6060728

DO - 10.3390/ph6060728

M3 - Article

C2 - 24276259

AN - SCOPUS:84878419915

VL - 6

SP - 728

EP - 758

JO - Pharmaceuticals

JF - Pharmaceuticals

SN - 1424-8247

IS - 6

ER -